Healthcare -
Biotechnology - NASDAQ - US
$ 9.865
-2.23 %
$ 1.02 B
Market Cap
-1.88
P/E
NTLA - SHORT-TERM DEBT
Short-term Debt NTLA - Intellia Therapeutics, Inc.
32.4 M
LAST VALUE
33.31%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR